02
April
2021
|
16:59
Asia/Singapore
Rapid, rigorous and robust: How Singapore approved its COVID-19 vaccines
2021 0402 Rapid, Rigorous And Robust: How Singapore Approved Its COVID-19 Vaccines
Professor John Lim, Executive Director of the Centre of Regulatory Excellence at Duke-NUS Medical School, explained how the approval of the COVID-19 vaccines was expedited, and shared how decades of work behind the scenes have positioned regulators to respond both rapidly and rigorously to outbreaks.
Click here to read more.
